Physician profile
Andre Ruela
NPI 1134734130
$756.44
in general payments reported to CMS, 2019-2025
10 companies · $728 in 2025
The $728 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.20 · 2024: $14.12 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $258.45 | 2025 | Synchromedii, Inceptiv, Accurian |
| Si-Bone, INC. | $131.39 | 2025 | |
| Protega Pharmaceutials INC | $114.46 | 2025 | Roxybond |
| Tonix Medicines, INC. | $72.65 | 2025 | Tonmya |
| Collegium Pharmaceutical, INC. | $44.29 | 2025 | Xtampza |
| Nalu Medical, INC. | $39.43 | 2025 | Nalu Neurostimulation System |
| Novo Nordisk INC | $28.32 | 2023-2024 | Wegovy |
| Valinor Pharma, LLC | $24.52 | 2025 | Movantik |
| Tersera Therapeutics LLC | $21.92 | 2025 | Prialt |
| Exact Sciences Corporation | $21.01 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Ruela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.